Literature DB >> 352939

Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity.

B Kaijser, P Larsson, S Olling.   

Abstract

Acute pyelonephritis in rats caused by Escherichia coli O6K13H1 produced serum and urinary antibodies against O6 and K13 antigens. This was also seen after intravesical immunization with Formalin-killed bacteria. Both intraperitoneal and intravesical immunization with these Formalin-killed bacteria protected against ascending urinary tract infection induced by homologous bacteria. Passive transfer of urine containing both O6 and K13 antibodies also protected against infection. By absorption experiments it was shown that K13 antibodies were especially important.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 352939      PMCID： PMC421554          DOI： 10.1128/iai.20.1.78-81.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  16 in total

1.  THE IMMUNOLOGIC STATUS OF THE HOST AND PYELONEPHRITIS: A STUDY OF RETROGRADE ESCHERICHIA COLI URINARY INFECTION IN RATS.

Authors:  J A ARANA; V M KOZIJ; G G JACKSON
Journal:  J Immunol       Date:  1965-03       Impact factor: 5.422

2.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

Authors:  E Engvall; P Perlmann
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

3.  Immunology of Escherichia coli: K antigen and its relation to urinary-tract infection.

Authors:  B Kaijser
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

4.  The role of antibody in experimental pyelonephritis.

Authors:  M Kyriakos; N S Ikari
Journal:  J Pathol       Date:  1969-03       Impact factor: 7.996

5.  The protective effect against E. coli of O and K antibodies of different immunoglobulin classes.

Authors:  B Kaijser; J Holmgren; L A Hanson
Journal:  Scand J Immunol       Date:  1972       Impact factor: 3.487

6.  The local immune response to Escherichia coli O and K antigen in experimental pyelonephritis.

Authors:  J W Smith; B Kaijser
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

7.  Characteristics of antibiotic-resistant Escherichia coli in the rectum of healthy school-children.

Authors:  G Lidin-Janson; E Falsen; U Jodal; B Kaijser; K Lincoln
Journal:  J Med Microbiol       Date:  1977-08       Impact factor: 2.472

8.  Frequency of E. coli K antigens in urinary-tract infections in children.

Authors:  B Kaijser; L A Hanson; U Jodal; G Lidin-Janson; J B Robbins
Journal:  Lancet       Date:  1977-03-26       Impact factor: 79.321

9.  Protective capacity of antibodies against Escherichia coli and K antigens.

Authors:  B Kaijser; S Ahlstedt
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

10.  The role of immunity in the pathogenesis of experimental hematogenous pyelonephritis.

Authors:  J P SANFORD; B W HUNTER; L L SOUDA
Journal:  J Exp Med       Date:  1962-02-01       Impact factor: 14.307
View more
  22 in total

1.  Urinary antibody response after immunisation with a vaccine against urinary tract infection.

Authors:  D Kruze; K Holzbecher; M Andrial; W Bossart
Journal:  Urol Res       Date:  1989

2.  Aggravation by morphine and D-aspartic acid of pyelonephritis induced by i.v. inoculation of Staphylococcus aureus in rats.

Authors:  H Koyuncuoğlu; M Güngör; O Anğ; D Inanç; M Anğ-Küçüker; H Sağduyu; V Uysal
Journal:  Infection       Date:  1988       Impact factor: 3.553

3.  A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.

Authors:  Thomas A Russo; Janet M Beanan; Ruth Olson; Stacy A Genagon; Ulrike MacDonald; John J Cope; Bruce A Davidson; Brian Johnston; James R Johnson
Journal:  Vaccine       Date:  2007-02-05       Impact factor: 3.641

4.  P-fimbriae vaccines. II. Cross reactive protection against pyelonephritis.

Authors:  J A Roberts; M B Kaack; G Baskin; T K Korhonen; S B Svenson; J Winberg
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

5.  Cellular basis of host defence in pyelonephritis. I. Chronic infection.

Authors:  T E Miller; G Findon; S Cawley
Journal:  Br J Exp Pathol       Date:  1986-02

6.  Experimental Escherichia coli ascending pyelonephritis in rats: changes in bacterial properties and the immune response to surface antigens.

Authors:  I Mattsby-Baltzer; L A Hanson; B Kaijser; P Larsson; S Olling; C Svanborg-Edén
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

7.  Experimental Escherichia coli ascending pyelonephritis in rats: active peroral immunization with live Escherichia coli.

Authors:  I Mattsby-Baltzer; L A Hanson; S Olling; B Kaijser
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

8.  Bacterial virulence versus host resistance in the urinary tracts of mice.

Authors:  C Svanborg-Edén; L Hagberg; R Hull; S Hull; K E Magnusson; L Ohman
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

9.  Non-antibiotic prevention of urinary tract infection.

Authors:  L Hagberg; H Leffler; C Svanborg Edén
Journal:  Infection       Date:  1985       Impact factor: 3.553

Review 10.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.